Compania de Minas Buenaventura SAA
BVN · NYSE
About BVN
- Employees
- 15,984
- Headquarters
- San Isidro, Lima
- Listed
- Nov 6, 1979
- Sector
- Materials
- Industry
- Metals & Mining
- Website
- buenaventura.com
BVN key statistics
- Market cap
- 7.61B
- Price-earnings ratio
- 6.44
- Dividend yield
- 3.79%
- Average volume
- 820.35K
- Volume
- 879.62K
- Open price
- $28.20
- High today
- $28.45
- Low today
- $27.36
- 52 Week high
- $44.02
- 52 Week low
- $21.00
Compania de Minas Buenaventura SAA (BVN) at a glance
As of Oct 23, 2026, Compania de Minas Buenaventura SAA (BVN) shares are priced at $27.92, giving the company a market cap of 7.61B, a price-to-earnings ratio of 6.44 and a dividend yield of 3.79%.
Today the stock has traded between $27.36 and $28.45. The current price is 2.0% above the day's low and 1.9% below its high.
Volume so far is 879.62K shares, in line with the average of 820.35K shares a day.
Over the past year Compania de Minas Buenaventura SAA has ranged from $21.00 to $44.02, and now sits 30% of the way up that range.
Compania de Minas Buenaventura SAA met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY26 it reported $1.32 per share against an estimate of $1.28.
The average analyst price target is $38.83, 39.1% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy50.0%
- Hold50.0%
- Sell0.0%
- Low
- $27.67
- Now
- $27.92
- High
- $52.50
BVN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 104.2% on average.
- Q2 FY24: reported $0.28 per share against an estimate of $0.3586
- Q3 FY24: reported $0.93 per share against an estimate of $0.236
- Q4 FY24: reported $0.13 per share against an estimate of $0.2091
- Q1 FY25: reported $0.58 per share against an estimate of $0.2722
- Q2 FY25: reported $0.40 per share against an estimate of $0.3454
- Q3 FY25: reported $0.71 per share against an estimate of $0.401
- Q4 FY25: reported $1.51 per share against an estimate of $0.6797
- Q1 FY26: reported $1.32 per share against an estimate of $1.28
BVN news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Buenaventura Cordially Invites You to Its Third Quarter 2026 Earnings Conference Call
- Press releaseBusiness Wire
Buenaventura to Host Investor Day on November 10, 2026 in New York
- Press releaseBusiness Wire
Buenaventura Announces Second Quarter 2026 Results
- Press releaseBusiness Wire
Buenaventura Announces Second Quarter 2026 Results for Production and Volume Sold per Metal
- Press releaseBusiness Wire
Buenaventura Cordially Invites You to Its Second Quarter 2026 Earnings Conference Call
- Press releaseBusiness Wire
Buenaventura Announces First Quarter Results
- Press releaseBusiness Wire
Buenaventura Announces First Quarter 2026 Results for Production and Volume Sold per Metal
Similar companies
Companies in the same industry as Compania de Minas Buenaventura SAA
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.